A Study for Elucidation of Functional Mechanism of High Molecular Weight Substances in Urine on Calcium Oxalate Stone Formation

阐明尿液中高分子物质对草酸钙结石形成作用机制的研究

基本信息

  • 批准号:
    12307032
  • 负责人:
  • 金额:
    $ 25.45万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2002
  • 项目状态:
    已结题

项目摘要

1. Study of crystal-cell interactions: An experimental model of calcium oxalate (CaOx) stones, suitable for investigation of crystal-cell interactions, has been established. It was confirmed that the phosphatidylserine exposure on the outer leaflet of the cell membrane of renal collecting duct cells could be evaluated quantitatively by using this model. Increased phosphatidylserine expressing cells and activation of the caspase family (intracellular signal transduction systems for apoptosis) were noted with increasing urinary oxalate excretion and calcium oxalate crystals. 2. Purification of stone-related proteins and their molecular biological analysis: Osteopontin (OPN) and calprotectin were purified. The adhesion of CaOx crystals to MDCK cells was promoted by OPN, while it was suppressed by thrombin and antisense oligonucleotide. It seems likely that OPN-DNA polymorphism in patients with urinary tract stones is involved in mutation of the enhancer regions that are related to synthes … More is of OPN protein. 3. OPN antisense gene transfer: The introduction of OPN antisense gene to renal tubular cells suppressed OPN expression and CaOx stone formation in the kidneys. The addition of OPN and vitronectin to renal tubular cells in culture elevated the intracellular expression of OPN and promoted the phosphorylation of focal adhesion kinase. Catechin suppressed the formation of CaOx crystals through inhibiting apoptosis induced by oxidative stress. 4. Study of urinary tract stone inhibitors using antisense gene: Human syndecan-1-expressing renal tubular cells were established. Heparan sulfate (HS) and HS proteoglycan were found to suppress the cellular injury by oxalate exposure and the adhesion of CaOx crystals to the cell surface. It was suggested that HS prevented the cell injury by serving as a charge barrier that inhibited the influx of oxalate ions into the cells. 5. Effects to stone formation by controlling the expression of stone-related protein mRNA: Increased expression of renal prothrombin F-1 (RPTF-1) mRNA in rat kidneys with CaOx was confirmed. In the macro-array analysis, it was noted that RPTF-1 protein, OPN gene, and the multiple genes encoding inflammatory systems were increased after CaOx crystal exposure to the renal tubular cells. Less
1.晶体细胞相互作用的研究:草酸钙(CaOx)结石的实验模型,适合于研究晶体细胞的相互作用,已经建立。结果表明,该模型可定量评价肾集合管细胞膜外叶磷脂酰丝氨酸的暴露量。随着尿草酸盐排泄和草酸钙结晶的增加,观察到表达磷脂酰丝氨酸的细胞增加和半胱天冬酶家族(细胞凋亡的细胞内信号转导系统)的激活。2.结石相关蛋白的纯化及其分子生物学分析:纯化骨桥蛋白(OPN)和钙卫蛋白。OPN可促进CaOx晶体与MDCK细胞的粘附,而凝血酶和反义寡核苷酸则可抑制CaOx晶体与MDCK细胞的粘附。尿路结石患者的OPN-DNA多态性可能与合成酶相关的增强子区域的突变有关。 ...更多信息 是OPN蛋白。3. OPN反义基因转移:将OPN反义基因导入肾小管细胞可抑制OPN表达和肾内CaOx结石形成。在培养的肾小管细胞中加入OPN和Vitronectin可提高细胞内OPN的表达,并促进黏着斑激酶的磷酸化。儿茶素通过抑制氧化应激诱导的细胞凋亡抑制CaOx晶体的形成。4.反义基因抑制尿路结石的研究:建立表达人syndecan-1的肾小管细胞。硫酸乙酰肝素(HS)和HS蛋白聚糖被发现可以抑制草酸暴露引起的细胞损伤和CaOx晶体粘附到细胞表面。结果表明,HS可作为一种电荷屏障,抑制草酸根离子进入细胞,从而防止细胞损伤。5.通过控制结石相关蛋白mRNA的表达对结石形成的影响:证实了CaOx大鼠肾脏中肾凝血酶原F-1(RPTF-1)mRNA的表达增加。在宏阵列分析中,注意到在CaOx晶体暴露于肾小管细胞后,RPTF-1蛋白、OPN基因和编码炎症系统的多个基因增加。少

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Konya E, et al.: "Influence of urinary sialic acid on calcium oxalate crystal formation"Urol Int.. 68(4). 281-285 (2002)
Konya E 等人:“尿唾液酸对草酸钙晶体形成的影响”Urol Int.. 68(4)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yasui Takahiro, et al.: "Effects of allopurinol on renal stone formation and osteopontin expression in a rat urolithiasis model"Nephron. 87. 170-176 (2001)
Yasui Takahiro 等人:“别嘌呤醇对大鼠尿石症模型中肾结石形成和骨桥蛋白表达的影响”肾单位。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yasui Takahiro, Kohri Kenjiro, et al.: "Calcium oxalate crystal attachment to cultured rat kidney epithelial cell. NRK-52E."Urologia Internationalis. 67. 73-76 (2001)
Yasui Takahiro、Kohri Kenjiro 等人:“草酸钙晶体附着在培养的大鼠肾上皮细胞上。NRK-52E。”Urologia Internationalis。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Konya Eiji, et al.: "Influence of urinary sialic acid on calcium oxalate crystal formation"Urol Int.. 68(4). 281-285 (2002)
Konya Eiji 等人:“尿唾液酸对草酸钙晶体形成的影响”Urol Int.. 68(4)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Mitsuhiko Okuyama, Sunao Yachiku, et al.: "Identification of bikunin isolated from human urine that inhibits calcium oxalate crystal growth and its localization in the kidneys"International Journal of Urology. 10, in printing. (2003)
Mitsuhiko Okuyama、Sunao Yachiku 等人:“鉴定从人尿中分离出的 Bikunin 抑制草酸钙晶体生长及其在肾脏中的定位”国际泌尿学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YACHIKU Sunao其他文献

YACHIKU Sunao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YACHIKU Sunao', 18)}}的其他基金

Effect of sex hormone on oxalate synthesizing enzyme in male and female rat livers.
性激素对雄性和雌性大鼠肝脏草酸合成酶的影响。
  • 批准号:
    09671599
  • 财政年份:
    1997
  • 资助金额:
    $ 25.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An analysis of bladder carcinomas by flow-cytometry
膀胱癌的流式细胞术分析
  • 批准号:
    62570715
  • 财政年份:
    1987
  • 资助金额:
    $ 25.45万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Demystify Heparan Sulfate–Sclerostin Interactions in Bone Formation
揭秘硫酸乙酰肝素与硬化素在骨形成中的相互作用
  • 批准号:
    10593214
  • 财政年份:
    2023
  • 资助金额:
    $ 25.45万
  • 项目类别:
Heparan sulfate as a platform to boost regulatory T cell suppression of autoimmunity
硫酸乙酰肝素作为增强调节性 T 细胞抑制自身免疫的平台
  • 批准号:
    490663
  • 财政年份:
    2023
  • 资助金额:
    $ 25.45万
  • 项目类别:
    Operating Grants
Heparan Sulfate in Prostate Cancer
硫酸乙酰肝素在前列腺癌中的作用
  • 批准号:
    10825084
  • 财政年份:
    2023
  • 资助金额:
    $ 25.45万
  • 项目类别:
Identifying Key Structural Interactions in Heparan Sulfate-Protein Complexes
鉴定硫酸乙酰肝素-蛋白质复合物中的关键结构相互作用
  • 批准号:
    10715985
  • 财政年份:
    2023
  • 资助金额:
    $ 25.45万
  • 项目类别:
Synthesis of the library of heparan sulfate hexasaccharide mimetics
硫酸乙酰肝素六糖模拟物文库的合成
  • 批准号:
    10759528
  • 财政年份:
    2023
  • 资助金额:
    $ 25.45万
  • 项目类别:
Development of a sensitive method to measure heparan sulfate 6-O-endosulfatase
开发一种灵敏的方法来测量硫酸乙酰肝素 6-O-内切硫酸酯酶
  • 批准号:
    10599763
  • 财政年份:
    2023
  • 资助金额:
    $ 25.45万
  • 项目类别:
Astrocytic Heparan Sulfate 6-O-Sulfation in Brain Function
星形细胞硫酸乙酰肝素 6-O-硫酸化对脑功能的影响
  • 批准号:
    10578904
  • 财政年份:
    2022
  • 资助金额:
    $ 25.45万
  • 项目类别:
Role of heparan sulfate in neural cell vulnerability to prions
硫酸乙酰肝素在神经细胞对朊病毒的脆弱性中的作用
  • 批准号:
    10684301
  • 财政年份:
    2022
  • 资助金额:
    $ 25.45万
  • 项目类别:
The role of heparan sulfate in cathepsin K biology
硫酸乙酰肝素在组织蛋白酶 K 生物学中的作用
  • 批准号:
    10665752
  • 财政年份:
    2022
  • 资助金额:
    $ 25.45万
  • 项目类别:
Microglial heparan sulfate in the modulation of APOE function and neurodegeneration
小胶质细胞硫酸乙酰肝素调节 APOE 功能和神经退行性变
  • 批准号:
    10555329
  • 财政年份:
    2022
  • 资助金额:
    $ 25.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了